论文部分内容阅读
本文45例诊断为肺鳞、腺癌、均不可手术治疗、KPS60~100分,治疗以丝裂霉素为主的联合化疗(MMC、DDP、ADM、CTX、VCR)、治疗3个周期,总有效率64%,T_3N_122例,获得CR5例,PR6例,R7例。T_2N_212例,获得CR1例,PR4例、MR3例、T_4N_211例、获得PR3例。KPS60~70分12例,获PR2例、R4。KPS80~100分33例,获得CR6例,PR8、MR9例生存范围6~30月、中数生存13月、治疗诱导的毒性骨髓抑制,白细胞最低0.9×10~9/L,血小板最低者6×10~9/L,经中西医结合治疗毒性很快缓解。
In this article, 45 cases were diagnosed as lung squamous cell carcinoma, all were inoperable, KPS was 60-100, treatment with mitomycin-based combination chemotherapy (MMC, DDP, ADM, CTX, VCR), treatment for 3 cycles, total The effective rate was 64%, T_3N_122 cases, CR 5 cases, PR 6 cases, R 7 cases. In T_2N_212 cases, CR1 cases were obtained, PR4 cases, MR3 cases, T_4N_211 cases, and PR3 cases. KPS 60 to 70 points in 12 cases, PR2 cases, R4. KPS 80 to 100 points in 33 cases, CR6 cases were obtained, PR8, MR9 survival range of 6 to 30 months, the median survival of 13 months, treatment-induced toxicity of bone marrow suppression, leukocyte minimum 0.9 10 9/L, platelet lowest 6 X 10~9/L, the toxicity of the combination of Chinese and Western medicine quickly relieved.